Novoprotein Scientific Inc. (SHA:688137)
China
· Delayed Price · Currency is CNY 32.27
+0.06 (0.19%)
At close: Apr 18, 2025, 2:57 PM CST
Novoprotein Scientific Revenue
In the year 2024, Novoprotein Scientific had annual revenue of 127.45M CNY, down -16.81%. Novoprotein Scientific had revenue of 35.37M in the quarter ending December 31, 2024, a decrease of -16.75%.
Revenue
127.45M
Revenue Growth
-16.81%
P/S Ratio
17.63
Revenue / Employee
220.12K
Employees
579
Market Cap
2.25B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
| Shanghai United Imaging Healthcare | 10.30B |